NYSE:EHAB - New York Stock Exchange, Inc. - US29332G1022 - Common Stock - Currency: USD
10.46
+0.18 (+1.75%)
The current stock price of EHAB is 10.46 USD. In the past month the price increased by 34.79%. In the past year, price increased by 26.79%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.44 | 85.60B | ||
CVS | CVS HEALTH CORP | 10.19 | 81.81B | ||
LH | LABCORP HOLDINGS INC | 17.04 | 21.00B | ||
DGX | QUEST DIAGNOSTICS INC | 19.14 | 19.64B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 17.9 | 16.50B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 125.71 | 13.64B | ||
HIMS | HIMS & HERS HEALTH INC | 80.01 | 12.35B | ||
DVA | DAVITA INC | 15.63 | 11.10B | ||
CHE | CHEMED CORP | 24.15 | 8.33B | ||
CRVL | CORVEL CORP | 27.29 | 5.86B | ||
OPCH | OPTION CARE HEALTH INC | 23.43 | 5.22B | ||
GH | GUARDANT HEALTH INC | N/A | 5.16B |
Enhabit, Inc. functions as an investment holding company. The company is headquartered in Dallas, Texas and currently employs 10,700 full-time employees. The company went IPO on 2022-06-23. Its segments include Home Health and Hospice. The Home Health segment provides a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. The company works closely with patients, families, caregivers, and physicians to deliver data-driven, evidence-based care plans focused on patient needs and goals. Its home health services are provided by nurses, physical, occupational and speech therapists, medical social workers, and home health aides. The Hospice segment provides hospice services to terminally ill patients and their families. Hospice care focuses on the quality of life for patients experiencing an advanced, life- limiting illness by treating the symptoms of the disease, rather than the disease itself. The company operates about 115 hospice agencies and 255 home health agencies.
ENHABIT INC
6688 N. Central Expressway, Suite 1300
Dallas TEXAS US
Employees: 10800
Phone: 14696216419
The current stock price of EHAB is 10.46 USD. The price increased by 1.75% in the last trading session.
The exchange symbol of ENHABIT INC is EHAB and it is listed on the New York Stock Exchange, Inc. exchange.
EHAB stock is listed on the New York Stock Exchange, Inc. exchange.
11 analysts have analysed EHAB and the average price target is 9.18 USD. This implies a price decrease of -12.24% is expected in the next year compared to the current price of 10.46. Check the ENHABIT INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ENHABIT INC (EHAB) has a market capitalization of 529.69M USD. This makes EHAB a Small Cap stock.
ENHABIT INC (EHAB) currently has 10800 employees.
ENHABIT INC (EHAB) has a support level at 8.14 and a resistance level at 10.47. Check the full technical report for a detailed analysis of EHAB support and resistance levels.
The Revenue of ENHABIT INC (EHAB) is expected to grow by 3.22% in the next year. Check the estimates tab for more information on the EHAB EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
EHAB does not pay a dividend.
ENHABIT INC (EHAB) will report earnings on 2025-08-04, after the market close.
The PE ratio for ENHABIT INC (EHAB) is 43.58. This is based on the reported non-GAAP earnings per share of 0.24 and the current share price of 10.46 USD. Check the full fundamental report for a full analysis of the valuation metrics for EHAB.
The outstanding short interest for ENHABIT INC (EHAB) is 2.72% of its float. Check the ownership tab for more information on the EHAB short interest.
ChartMill assigns a technical rating of 9 / 10 to EHAB. When comparing the yearly performance of all stocks, EHAB is one of the better performing stocks in the market, outperforming 92.44% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to EHAB. EHAB has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months EHAB reported a non-GAAP Earnings per Share(EPS) of 0.24. The EPS increased by 20% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -12.74% | ||
ROE | -29.84% | ||
Debt/Equity | 0.94 |
ChartMill assigns a Buy % Consensus number of 76% to EHAB. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 85.38% and a revenue growth 3.22% for EHAB